The world's first mRNA vaccine against a deadly disease

Published Date: 15 Mar 2023

A world first: A research team from Tel Aviv University and the Israel Institute of Biology has developed an anti-mRNA drug that is 100% effective against a single type of virus.

Read Full News

Latest News

HES in a Young Girl With Serous Effusions

A previously healthy 4-year-old develops pleural and pericardial effusions with marked eosinophilia after infection and malignancy are excluded, confirming HES.

Trump, Kennedy Seek to Relax AI Healthcare Safeguards Rules

AI scribes save doctors time, but critics warn that poor note accuracy and newly proposed federal rollbacks on safety rules could put patient health at risk.

Mirvetuximab Signals a New Era in Ovarian Care

Mirvetuximab’s approval for FR alpha-positive, platinum-resistant disease marks a precision-medicine milestone, opening opportunities for ADCs while highlighting the need for assay standardization and safety plans.

Professional Corner: Brain-Heart Grants, AMA Podcast, & More

Neuroscientists receive support for exercise-related research. The American Medical Association takes on wellness trends. And a new medical school opens in New York state.

Uveitis in Children Tied to Higher Inflammatory Disease Risk

Children and adolescents with noninfectious uveitis face an increased risk of developing immune-mediated inflammatory diseases compared with their peers in the general population.

CDC Aiding Withdrawal of Affected Americans After Ebola Outbreak in Congo, Uganda

The U.S. Centers for Disease Control and Prevention said on Sunday it mobilized response efforts following an ⁠Ebola outbreak in the Democratic Republic of Congo and Uganda,...

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Todays Updates

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

Revolutionary Cancer Tx Could Transform Autoimmune Disease

Researchers are testing CAR T-cell therapy as a way to reset the immune system in lupus, Graves’ disease and other conditions where the body’s defenses go rogue.

Latest News

A previously healthy 4-year-old develops pleural and pericardial effusions with marked eosinophilia after infection and malignancy are excluded, confirming HES.

AI scribes save doctors time, but critics warn that poor note accuracy and newly proposed federal rollbacks on safety rules could put patient health at risk.

Mirvetuximab’s approval for FR alpha-positive, platinum-resistant disease marks a precision-medicine milestone, opening opportunities for ADCs while highlighting the need for assay standardization and safety plans.

Neuroscientists receive support for exercise-related research. The American Medical Association takes on wellness trends. And a new medical school opens in New York state.

Children and adolescents with noninfectious uveitis face an increased risk of developing immune-mediated inflammatory diseases compared with their peers in the general population.

The U.S. Centers for Disease Control and Prevention said on Sunday it mobilized response efforts following an ⁠Ebola outbreak in the Democratic Republic of Congo and Uganda,...

News All Time

Novel IL-17A Inhibitor Shows Efficacy in Axial SpA

Compared with placebo, vunakizumab 120 mg significantly improves signs and symptoms of radiographic axial spondyloarthritis at week 16, with sustained efficacy through week 32.

Combo Therapy Tied to Better Quality of Life in Rhinitis

In patients with allergic rhinitis, fixed combinations of intranasal antihistamines and corticosteroids are tied to better quality-of-life outcomes than oral or intranasal antihistamines alone.

Pinpoint Giant Cell Arteritis in Primary Care

New treatments for giant cell arteritis offer steroid-free remission but require primary care clinicians to monitor for serious cardiovascular and infection risks.

Hantavirus Risk to US Public Remains Low, CDC Says

The risk from hantavirus to the general public remains very low, ⁠and the U.S. Centers for Disease Control and Prevention has more than 100 staff members actively working on...

Chronic Cough Tied to Greater Healthcare Burden

Unexplained or refractory chronic cough affects a small fraction of individuals but is associated with impaired health status, a higher number of medical visits, and higher healthcare costs.

Gut Microbe Blooms Linked to Lupus Kidney Disease

Intestinal blooms of Ruminococcus gnavus, which produce a novel lipoglycan toxin, are linked to a distinct lupus nephritis endotype characterized by platelet activation and neutrophil degranulation.

Scarring Alopecias More Common in Black People, Urban Areas

Primary lymphocytic cicatricial alopecias disproportionately affect women, Black individuals, and urban dwellers, a study finds.

Britain to Bring 10 People to UK for Precautionary Isolation After Hantavirus Outbreak

Britain said on Tuesday that 10 people from remote island territories, including cruise ship passengers and ⁠medical staff who had contact with confirmed cases in the...

Tests in Italy, Spain Come Back Negative in Global Hunt for Hantavirus

Seventeen people under observation in Italy and Spain for possible hantavirus infection have tested negative, the countries' health ministries said on Wednesday as...

NICE Clears Home Antibiotics for Stable Newborns

Updated NICE guidance allows stable newborns to switch to oral antibiotics and complete their course at home, potentially cutting hospital stays by nearly 3 days.

Guideline Advises on New Drug for ILD in Rheumatic Diseases

The British Society for Rheumatology has produced its first guidelines for the diagnosis and management of systemic autoimmune rheumatic disease-associated interstitial lung disease.

Transplant-Related Immunosuppression Drives SCC Outcomes

While most clinicians are aware of the link between immunosuppression and poor outcomes, this study validates that link and clarifies the type of immunosuppression associated with the greatest risk.

TNF Plus IL-23 Inhibition for PsA: Better Than IL-23 Alone?

Patients with active psoriatic arthritis who have an inadequate response to TNF inhibitors, mainly those with elevated C-reactive protein levels, may benefit from guselkumab plus golimumab therapy.

Is ChatGPT Health Ready for Emergency Triage?

Large language models performed better after full clinical data became available, raising concerns about early triage decision-making.

Ultraprocessed Food Intake Tied to High Asthma Risk in Kids

High consumption of heavily processed foods is linked to an increased risk for asthma in young children during early school years.

New Data Peg Three Key Steps for Reassuring Worried Patients

Missing even one of the steps can leave patients feeling unsatisfied, frustrated, or dismissed, new research suggests.

Recommended News For You

On all CAR-T products, the FDA is calling for a new boxed warning.

In MDS at Lower Risk, Novel Therapy Diminished Transfusion Dependency.

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

Why breast cancer survivors don't take their medicine, and what can be done about it.

Use of social media during pregnancy may increase depression.

Healthcare in the Mix in President Biden's Farewell Address

June 20, 2023, Health Bulletin No. 12.

Recommended Articles For You

Unlocking the Potential of Talquetamab: A Revolutionary Approach to Cancer Treatment 

Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy 

Tertiary Lymphoid Structures in Cancer: Advancing Therapeutic Implications 

The Algorithmic Revolution: How AI is Reshaping Precision Oncology from Bench to Bedside 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer care crowdfunding increasingly common, but rarely successful

2.

First-Line HCC Trial's Lenvatinib-Pembrolizumab Combo Misses Target.

3.

Researchers discover that children who survive cancer have socioeconomic challenges.

4.

Could CT scans be fueling a future rise in cancer cases, as a new study suggests?

5.

SBRT May Beat Brachytherapy in Prostate Cancer

1.

Exploring the Normal Range of Monocytes: A Comprehensive Guide

2.

Breast Cancer Recovery: Fashion, Function, and Healing Beyond Scars

3.

Tailoring the Immune Response: The Dawn of Personalized Vaccines in Cancer Immunotherapy

4.

Value, Access, and Affordability in Next-Gen Oncology: Navigating Costs, Coverage, and Clinical Impact

5.

The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

A New Era in Managing Cancer-Associated Thrombosis

2.

An Intro to The Multifaceted Advantages of CDK4/6 Inhibitors in HR+/HER2- Advanced Breast Cancer Clinical Studies.

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VII

5.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot